| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 4028 | 1998 |
| Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ... New England Journal of Medicine 346 (21), 1616-1622, 2002 | 1900 | 2002 |
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ... Jama 304 (9), 967-975, 2010 | 1778 | 2010 |
| Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ... Journal of clinical oncology 22 (6), 1055-1062, 2004 | 1563 | 2004 |
| Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers TR Rebbeck, ND Kauff, SM Domchek Journal of the National Cancer Institute 101 (2), 80-87, 2009 | 1166 | 2009 |
| Metabolic gene polymorphism frequencies in control populations S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ... Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001 | 1147 | 2001 |
| Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. TR Rebbeck Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1997 | 1083 | 1997 |
| Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program MS Brose, TR Rebbeck, KA Calzone, JE Stopfer, KL Nathanson, ... Journal of the National Cancer Institute 94 (18), 1365-1372, 2002 | 993 | 2002 |
| Type I and II endometrial cancers: have they different risk factors? VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ... Journal of Clinical Oncology 31 (20), 2607-2618, 2013 | 978 | 2013 |
| BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer FJ Couch, ML DeShano, MA Blackwood, K Calzone, J Stopfer, ... New England Journal of Medicine 336 (20), 1409-1415, 1997 | 945 | 1997 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 826 | 2012 |
| Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers TR Rebbeck, AM Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, ... Journal of the National Cancer Institute 91 (17), 1475-1479, 1999 | 822 | 1999 |
| Early detection of cancer D Crosby, S Bhatia, KM Brindle, LM Coussens, C Dive, M Emberton, ... Science 375 (6586), eaay9040, 2022 | 745 | 2022 |
| Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ... Journal of clinical oncology 26 (8), 1331-1337, 2008 | 726 | 2008 |
| Comprehensive genomic characterization of long non-coding RNAs across human cancers X Yan, Z Hu, Y Feng, X Hu, J Yuan, SD Zhao, Y Zhang, L Yang, W Shan, ... Cancer cell 28 (4), 529-540, 2015 | 679 | 2015 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 662 | 2013 |
| Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities RB Warnecke, A Oh, N Breen, S Gehlert, E Paskett, KL Tucker, N Lurie, ... American journal of public health 98 (9), 1608-1615, 2008 | 651 | 2008 |
| Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 TR Rebbeck, JM Jaffe, AH Walker, AJ Wein, SB Malkowicz JNCI: Journal of the National Cancer Institute 90 (16), 1225-1229, 1998 | 640 | 1998 |
| Assessment of cumulative evidence on genetic associations: interim guidelines JPA Ioannidis, P Boffetta, J Little, TR O’Brien, AG Uitterlinden, P Vineis, ... International journal of epidemiology 37 (1), 120-132, 2008 | 634 | 2008 |
| Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation JV Lee, A Carrer, S Shah, NW Snyder, S Wei, S Venneti, AJ Worth, ... Cell metabolism 20 (2), 306-319, 2014 | 601 | 2014 |
